Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 20569070)


Immune signatures predict prognosis in localized cancer.

Hsu DS, Kim MK, Balakumaran BS, Acharya CR, Anders CK, Clay T, Lyerly HK, Drake CG, Morse MA, Febbo PG.

Cancer Invest. 2010 Aug;28(7):765-73. doi: 10.3109/07357900903095755.


Molecular profiling of multiple human cancers defines an inflammatory cancer-associated molecular pattern and uncovers KPNA2 as a uniform poor prognostic cancer marker.

Rachidi SM, Qin T, Sun S, Zheng WJ, Li Z.

PLoS One. 2013;8(3):e57911. doi: 10.1371/journal.pone.0057911. Epub 2013 Mar 25.


Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma.

Nguyen GH, Schetter AJ, Chou DB, Bowman ED, Zhao R, Hawkes JE, Mathé EA, Kumamoto K, Zhao Y, Budhu A, Hagiwara N, Wang XW, Miyashita M, Casson AG, Harris CC.

Clin Cancer Res. 2010 Dec 1;16(23):5824-34. doi: 10.1158/1078-0432.CCR-10-1110. Epub 2010 Oct 14.


Identification of common prognostic gene expression signatures with biological meanings from microarray gene expression datasets.

Yao J, Zhao Q, Yuan Y, Zhang L, Liu X, Yung WK, Weinstein JN.

PLoS One. 2012;7(9):e45894. doi: 10.1371/journal.pone.0045894. Epub 2012 Sep 21.


Distinct signatures of the immune responses in low risk versus high risk neuroblastoma.

Gowda M, Godder K, Kmieciak M, Worschech A, Ascierto ML, Wang E, Marincola FM, Manjili MH.

J Transl Med. 2011 Oct 6;9:170. doi: 10.1186/1479-5876-9-170.


The humoral immune system has a key prognostic impact in node-negative breast cancer.

Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, Pilch H, Lehr HA, Hengstler JG, Kölbl H, Gehrmann M.

Cancer Res. 2008 Jul 1;68(13):5405-13. doi: 10.1158/0008-5472.CAN-07-5206.


Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape.

Taube JM, Anders RA, Young GD, Xu H, Sharma R, McMiller TL, Chen S, Klein AP, Pardoll DM, Topalian SL, Chen L.

Sci Transl Med. 2012 Mar 28;4(127):127ra37. doi: 10.1126/scitranslmed.3003689.


Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer.

Winther M, Alsner J, Tramm T, Nordsmark M.

Acta Oncol. 2013 Oct;52(7):1327-35. doi: 10.3109/0284186X.2013.818247. Epub 2013 Aug 19.


An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer.

Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas C.

Genome Biol. 2007;8(8):R157.


Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.

Quan L, Gong Z, Yao S, Bandera EV, Zirpoli G, Hwang H, Roberts M, Ciupak G, Davis W, Sucheston L, Pawlish K, Bovbjerg DH, Jandorf L, Cabasag C, Coignet JG, Ambrosone CB, Hong CC.

Int J Cancer. 2014 Mar 15;134(6):1408-21. doi: 10.1002/ijc.28458. Epub 2013 Oct 8.


Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma.

Wan YW, Beer DG, Guo NL.

Lung Cancer. 2012 Apr;76(1):98-105. doi: 10.1016/j.lungcan.2011.09.016. Epub 2011 Nov 1.


[Prognostic molecular classification of breast cancers based on gene expression profiling].

Feng YM, Li XQ, Sun BC, Gao XC, Gu L, Niu Y, Hao XS.

Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):900-6. Chinese.


Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.

Johansson I, Nilsson C, Berglund P, Lauss M, Ringnér M, Olsson H, Luts L, Sim E, Thorstensson S, Fjällskog ML, Hedenfalk I.

Breast Cancer Res. 2012 Feb 14;14(1):R31.


Epidermal growth factor receptor tyrosine kinase defines critical prognostic genes of stage I lung adenocarcinoma.

Yamauchi M, Yamaguchi R, Nakata A, Kohno T, Nagasaki M, Shimamura T, Imoto S, Saito A, Ueno K, Hatanaka Y, Yoshida R, Higuchi T, Nomura M, Beer DG, Yokota J, Miyano S, Gotoh N.

PLoS One. 2012;7(9):e43923. doi: 10.1371/journal.pone.0043923. Epub 2012 Sep 19.


Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.

Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, Dekan G, Vogl S, Kubista E, Heider KH, Stratowa C, Schreiber M, Sommergruber W.

Cancer Res. 2004 Feb 1;64(3):844-56.


Systems biology analysis of gene expression during in vivo Mycobacterium avium paratuberculosis enteric colonization reveals role for immune tolerance.

Khare S, Lawhon SD, Drake KL, Nunes JE, Figueiredo JF, Rossetti CA, Gull T, Everts RE, Lewin HA, Galindo CL, Garner HR, Adams LG.

PLoS One. 2012;7(8):e42127. doi: 10.1371/journal.pone.0042127. Epub 2012 Aug 17.


Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.

Chang W, Gao X, Han Y, Du Y, Liu Q, Wang L, Tan X, Zhang Q, Liu Y, Zhu Y, Yu Y, Fan X, Zhang H, Zhou W, Wang J, Fu C, Cao G.

Gut. 2014 Sep;63(9):1457-67. doi: 10.1136/gutjnl-2013-305475. Epub 2013 Oct 30.


T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

Rody A, Holtrich U, Pusztai L, Liedtke C, Gaetje R, Ruckhaeberle E, Solbach C, Hanker L, Ahr A, Metzler D, Engels K, Karn T, Kaufmann M.

Breast Cancer Res. 2009;11(2):R15. doi: 10.1186/bcr2234. Epub 2009 Mar 9.


Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.

Bain GH, Collie-Duguid E, Murray GI, Gilbert FJ, Denison A, McKiddie F, Ahearn T, Fleming I, Leeds J, Phull P, Park K, Nanthakumaran S, Grabsch HI, Tan P, Welch A, Schweiger L, Dahle-Smith A, Urquhart G, Finegan M, Petty RD.

Br J Cancer. 2014 Mar 18;110(6):1525-34. doi: 10.1038/bjc.2014.45. Epub 2014 Feb 25.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk